Lymphovascular invasion in colorectal cancer: an interobserver variability study.
BACKGROUND
Lymphovascular invasion (LVI) in colorectal cancer (CRC) is considered a strong stage-independent prognostic factor and influences decisions regarding adjuvant chemotherapy in patients with stage II tumors. However, the degree of interobserver agreement among pathologists for LVI in CRC is largely unknown. This study was undertaken to examine such interobserver variability, and we hypothesized that the use of immunohistochemical markers for vascular and lymphatic channels could improve interobserver agreement.


METHODS
Fifty cases of American Joint Committee on Cancer stage II moderately differentiated CRC from 1990 to 2005 from the pathology archives were selected; mucinous, medullary, and other recognized special subtypes were excluded. Fifty hematoxylin and eosin (H&E) slides (1 from each case) were circulated to 6 gastrointestinal pathologists, who independently assessed small and large vessel invasion. No diagnostic guidelines were given to the participating pathologists; each was instructed to apply the criteria for LVI that he or she used in daily practice. Immunohistochemistry (IHC) for D2-40 and CD31 was performed on corresponding paraffin blocks. The IHC slides were randomized, recirculated, and rescored for LVI. Results were analyzed by kappa (kappa) statistics, which correct for agreement by chance, and for percentage agreement.


RESULTS
The average kappa values were determined for the H&E slides (large and small vessel), CD31 (small vessel), and D2-40 (small vessel) (Fig. 1). Agreement was fair for H&E small vessel invasion [kappa=0.28; 95% confidence interval (CI): 0.22-0.34]. The least agreement was seen in interpretation of H&E large vessel invasion (kappa=0.18; 95%CI: 0.11-0.26). Agreement was not improved by use of immunohistochemical stains: CD31 (large vessel, kappa=0.42, 95%CI: 0.20-0.63, small vessel, kappa=0.26, 95%CI: 0.10-0.42) and D2-40 (kappa=0.32, 95%CI: 0.21-0.42).


CONCLUSIONS
Interobserver variability in diagnosis of LVI was substantial on H&E slides and did not improve upon use of IHC. Agreement in evaluation of large vessel invasion was only slightly higher than would be seen by chance alone. This study highlights the need for criteria in evaluation of LVI, as this assessment may impact patient prognosis and thus change the course of clinical treatment.
Harris
Elizabeth I
EI
Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Elizabeth.harris@vanderbilt.edu
Lewin
David N
DN
Wang
Hanlin L
HL
Lauwers
Gregory Y
GY
Srivastava
Amitabh
A
Shyr
Yu
Y
Shakhtour
Bashar
B
Revetta
Frank
F
Washington
Mary K
MK
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis / Q000175:diagnosis*; D042601:Lymphatic Vessels / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000175:diagnosis; D015588:Observer Variation; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000096:biosynthesis
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019408:Platelet Endothelial Cell Adhesion Molecule-1; C500987:monoclonal antibody D2-40
Am J Surg. 1981 Jan;141(1):15-7
7457719
Cancer. 1994 Apr 15;73(8):2076-82
8156513
J Clin Pathol. 2004 Jul;57(7):769-72
15220375
Cancer. 1988 Mar 1;61(5):1018-23
3338045
Arch Pathol Lab Med. 2006 Mar;130(3):318-24
16519558
Cancer. 1996 Dec 1;78(11):2313-7
8941000
J Clin Pathol. 1981 May;34(5):509-13
7251893
Dis Colon Rectum. 1991 Apr;34(4):323-8
1848810
Br J Surg. 2006 Jul;93(7):866-71
16622901
Oncol Rep. 2004 Jan;11(1):47-50
14654901
Dis Colon Rectum. 2007 Nov;50(11):1867-72
17665249
Cancer. 1992 Jan 15;69(2):322-6
1728363
Br J Surg. 1980 Jun;67(6):439-42
7388345
Cancer. 1989 Nov 1;64(9):1937-47
2477139
Am J Surg. 2005 Jun;189(6):707-13
15910724
Pathol Res Pract. 2006;202(9):663-70
16860493
Histopathology. 2006 Nov;49(5):487-92
17064294
Cancer. 2000 Apr 1;88(7):1739-57
10738234
J Clin Pathol. 2002 Jan;55(1):17-21
11825918
Am J Clin Pathol. 1999 Jan;111(1):51-8
9894454
Cancer. 1990 Sep 1;66(5):972-7
2167149
Eur Surg Res. 2006;38(5):438-44
16912482
Cancer. 1988 Apr 1;61(7):1417-24
3345494
Histopathology. 1981 Mar;5(2):141-63
7216178
Dis Colon Rectum. 1991 Sep;34(9):798-804
1914747
Gut. 1991 Jul;32(7):774-8
1855684
Gut. 1989 Oct;30(10):1385-91
2583564
J Clin Oncol. 1988 Jan;6(1):119-27
2826712
Hum Pathol. 1982 Feb;13(2):170-2
7076201
Cancer. 1994 Jun 1;73(11):2716-20
8194011
Arch Pathol Lab Med. 2000 Jul;124(7):979-94
10888773
Dis Colon Rectum. 1983 Sep;26(9):613-7
6872793